Back to Trades
LINDAHL RICHARD S
EVP, Chief Financial OfficerCIK: 0001196632
LINDAHL RICHARD S, EVP, Chief Financial Officer, has filed 5 insider trading reports covering 1 company. Total disclosed trading volume is $3.7M. Purchases and sales are approximately balanced over this period. The largest single filing involves Emergent BioSolutions Inc. (EBS). All transactions sourced from SEC Form 4 filings.
Total Volume
$3.7M
Purchases
$0
Sales
$0
Companies
1
Trading History (5 filings)
Grant
$0
1 grant
Other
$0
Other
$0
Other
$0
Other
$0